| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Matthew Large, Marta Di Forti, Robin Murra. Cannabis: debated schizophrenia link. Nature. vol 527. issue 7578. 2016-05-12. PMID:26581281. |
cannabis: debated schizophrenia link. |
2016-05-12 |
2023-08-13 |
Not clear |
| G N Giordano, H Ohlsson, K Sundquist, J Sundquist, K S Kendle. The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. Psychological medicine. vol 45. issue 2. 2016-04-14. PMID:24990397. |
the association between cannabis abuse and subsequent schizophrenia: a swedish national co-relative control study. |
2016-04-14 |
2023-08-13 |
Not clear |
| Paula Suárez-Pinilla, Roberto Roiz-Santiañez, Víctor Ortiz-García de la Foz, Paul C Guest, Rosa Ayesa-Arriola, Aldo Córdova-Palomera, Diana Tordesillas-Gutierrez, Benedicto Crespo-Facorr. Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. Psychiatry research. vol 233. issue 2. 2016-03-29. PMID:26071625. |
cannabinoid receptor 1 (cnr1) gene polymorphisms have been associated with central and peripheral effects of cannabis and schizophrenia pathophysiology. |
2016-03-29 |
2023-08-13 |
Not clear |
| Behdin Nowrouzi, Roy Kamhi, Jayi Hu, James L Kennedy, Michelle Matmari, Vincenzo De Luc. Age at onset mixture analysis and systematic comparison in schizophrenia spectrum disorders: Is the onset heterogeneity dependent on heterogeneous diagnosis? Schizophrenia research. vol 164. issue 1-3. 2016-03-23. PMID:25818628. |
overall, our study showed that a typical early onset schizophrenia patient is more likely to be a white male with cannabis abuse and positive family history of psychiatric disorders. |
2016-03-23 |
2023-08-13 |
human |
| Dalena van Heugten-Van der Kloet, Timo Giesbrecht, Janelle van Wel, Wendy M Bosker, Kim P C Kuypers, Eef L Theunissen, Desirée B Spronk, Robbert Jan Verkes, Harald Merckelbach, Johannes G Ramaeker. MDMA, cannabis, and cocaine produce acute dissociative symptoms. Psychiatry research. vol 228. issue 3. 2016-03-18. PMID:26003508. |
dissociative symptoms following mdma and cannabis largely exceeded those observed in schizophrenia patients, were comparable with those observed in special forces soldiers undergoing survival training, but were lower compared with ketamine-induced dissociation. |
2016-03-18 |
2023-08-13 |
human |
| Filippo Dragogna, Massimo C Mauri, Giorgio Marotta, F Teodora Armao, Paolo Brambilla, A Carlo Altamur. Brain metabolism in substance-induced psychosis and schizophrenia: a preliminary PET study. Neuropsychobiology. vol 70. issue 4. 2016-02-29. PMID:25471704. |
the relation between schizophrenia and cannabis abuse has been widely discussed from etiopathogenetic, psychopathological and neurometabolic points of view. |
2016-02-29 |
2023-08-13 |
Not clear |
| Filippo Dragogna, Massimo C Mauri, Giorgio Marotta, F Teodora Armao, Paolo Brambilla, A Carlo Altamur. Brain metabolism in substance-induced psychosis and schizophrenia: a preliminary PET study. Neuropsychobiology. vol 70. issue 4. 2016-02-29. PMID:25471704. |
relatively little has been written about the differences between schizophrenia with co-occurrent cannabis abuse and substance-induced psychotic disorder (sipd). |
2016-02-29 |
2023-08-13 |
Not clear |
| Matthijs G Bossong, Mitul A Mehta, Bart N M van Berckel, Oliver D Howes, René S Kahn, Paul R A Stoke. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. vol 232. issue 15. 2016-02-23. PMID:25801289. |
accumulating epidemiological evidence indicates that cannabis use is a risk factor for the development of schizophrenia. |
2016-02-23 |
2023-08-13 |
human |
| Kelly E Gill, Lucy Poe, Neyra Azimov, Shelly Ben-David, Nehal P Vadhan, Ragy Girgis, Holly Moore, Victoria Cressman, Cheryl M Corcora. Reasons for cannabis use among youths at ultra high risk for psychosis. Early intervention in psychiatry. vol 9. issue 3. 2016-02-19. PMID:24274357. |
cannabis use is prevalent in schizophrenia and its risk states, despite its association with anxiety and positive symptoms. |
2016-02-19 |
2023-08-12 |
Not clear |
| Kelly E Gill, Lucy Poe, Neyra Azimov, Shelly Ben-David, Nehal P Vadhan, Ragy Girgis, Holly Moore, Victoria Cressman, Cheryl M Corcora. Reasons for cannabis use among youths at ultra high risk for psychosis. Early intervention in psychiatry. vol 9. issue 3. 2016-02-19. PMID:24274357. |
while schizophrenia patients report using cannabis for mood enhancement and social motives, it is not known what motivates clinical high risk (chr) patients to use cannabis. |
2016-02-19 |
2023-08-12 |
Not clear |
| Jonathan A Pushpa-Rajah, Benjamin C McLoughlin, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. Schizophrenia bulletin. vol 41. issue 2. 2016-01-25. PMID:25552590. |
cannabis and schizophrenia. |
2016-01-25 |
2023-08-13 |
Not clear |
| Jonathan A Pushpa-Rajah, Benjamin C McLoughlin, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. Schizophrenia bulletin. vol 41. issue 2. 2016-01-25. PMID:25552590. |
many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. |
2016-01-25 |
2023-08-13 |
Not clear |
| Jonathan A Pushpa-Rajah, Benjamin C McLoughlin, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. Schizophrenia bulletin. vol 41. issue 2. 2016-01-25. PMID:25552590. |
it is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake. |
2016-01-25 |
2023-08-13 |
Not clear |
| Jessica A Wojtalik, Susan S Hogarty, Jack R Cornelius, Mary L Phillips, Matcheri S Keshavan, Christina E Newhill, Shaun M Eac. Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study. Frontiers in psychiatry. vol 6. 2016-01-21. PMID:26793128. |
cognitive enhancement therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. |
2016-01-21 |
2023-08-13 |
Not clear |
| Jessica A Wojtalik, Susan S Hogarty, Jack R Cornelius, Mary L Phillips, Matcheri S Keshavan, Christina E Newhill, Shaun M Eac. Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study. Frontiers in psychiatry. vol 6. 2016-01-21. PMID:26793128. |
a small sample of outpatients with schizophrenia and alcohol and/or cannabis substance use problems participating in an 18-month randomized trial of cet (n = 10) or usual care (n = 4) completed posttreatment functional neuroimaging using an emotion regulation task. |
2016-01-21 |
2023-08-13 |
Not clear |
| Alain Dervaux, Marie-Odile Krebs, Xavier Laqueill. [Cannabis-induced cognitive and psychiatric disorders]. Bulletin de l'Academie nationale de medecine. vol 198. issue 3. 2016-01-19. PMID:26427297. |
a higher risk of schizophrenia is predicted by earlier onset of cannabis use. |
2016-01-19 |
2023-08-13 |
human |
| Leon French, Courtney Gray, Gabriel Leonard, Michel Perron, G Bruce Pike, Louis Richer, Jean R Séguin, Suzanne Veillette, C John Evans, Eric Artiges, Tobias Banaschewski, Arun W L Bokde, Uli Bromberg, Ruediger Bruehl, Christian Buchel, Anna Cattrell, Patricia J Conrod, Herta Flor, Vincent Frouin, Jurgen Gallinat, Hugh Garavan, Penny Gowland, Andreas Heinz, Herve Lemaitre, Jean-Luc Martinot, Frauke Nees, Dimitri Papadopoulos Orfanos, Melissa Marie Pangelinan, Luise Poustka, Marcella Rietschel, Michael N Smolka, Henrik Walter, Robert Whelan, Nic J Timpson, Gunter Schumann, George Davey Smith, Zdenka Pausova, Tomáš Pau. Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence. JAMA psychiatry. vol 72. issue 10. 2016-01-12. PMID:26308966. |
early cannabis use, polygenic risk score for schizophrenia and brain maturation in adolescence. |
2016-01-12 |
2023-08-13 |
Not clear |
| Leon French, Courtney Gray, Gabriel Leonard, Michel Perron, G Bruce Pike, Louis Richer, Jean R Séguin, Suzanne Veillette, C John Evans, Eric Artiges, Tobias Banaschewski, Arun W L Bokde, Uli Bromberg, Ruediger Bruehl, Christian Buchel, Anna Cattrell, Patricia J Conrod, Herta Flor, Vincent Frouin, Jurgen Gallinat, Hugh Garavan, Penny Gowland, Andreas Heinz, Herve Lemaitre, Jean-Luc Martinot, Frauke Nees, Dimitri Papadopoulos Orfanos, Melissa Marie Pangelinan, Luise Poustka, Marcella Rietschel, Michael N Smolka, Henrik Walter, Robert Whelan, Nic J Timpson, Gunter Schumann, George Davey Smith, Zdenka Pausova, Tomáš Pau. Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence. JAMA psychiatry. vol 72. issue 10. 2016-01-12. PMID:26308966. |
cannabis use during adolescence is known to increase the risk for schizophrenia in men. |
2016-01-12 |
2023-08-13 |
Not clear |
| Katherine A Epstein, Sanjiv Kumr. Altered cortical maturation in adolescent cannabis users with and without schizophrenia. Schizophrenia research. vol 162. issue 1-3. 2016-01-04. PMID:25600549. |
altered cortical maturation in adolescent cannabis users with and without schizophrenia. |
2016-01-04 |
2023-08-13 |
human |
| Katherine A Epstein, Sanjiv Kumr. Altered cortical maturation in adolescent cannabis users with and without schizophrenia. Schizophrenia research. vol 162. issue 1-3. 2016-01-04. PMID:25600549. |
however, the impact of cannabis use disorder (cud) upon cortical gray matter development in both healthy adolescents and adolescents with early-onset schizophrenia (eos) is unclear. |
2016-01-04 |
2023-08-13 |
human |